Hims & Hers Health, Inc. (HIMS): Price and Financial Metrics
GET POWR RATINGS... FREE!
HIMS POWR Grades
- Growth is the dimension where HIMS ranks best; there it ranks ahead of 65.92% of US stocks.
- The strongest trend for HIMS is in Sentiment, which has been heading down over the past 179 days.
- HIMS ranks lowest in Stability; there it ranks in the 6th percentile.
HIMS Stock Summary
- HIMS's went public 2.7 years ago, making it older than merely 7.68% of listed US stocks we're tracking.
- The ratio of debt to operating expenses for Hims & Hers Health Inc is higher than it is for about merely 6.52% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Hims & Hers Health Inc is reporting a growth rate of 516.31%; that's higher than 95.84% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Hims & Hers Health Inc are CRTD, GRIL, ASLE, WNS, and WMS.
- HIMS's SEC filings can be seen here. And to visit Hims & Hers Health Inc's official web site, go to www.forhims.com.
HIMS Valuation Summary
- HIMS's EV/EBIT ratio is -19.6; this is 208.89% lower than that of the median Consumer Defensive stock.
- HIMS's price/sales ratio has moved NA NA over the prior 26 months.
- HIMS's price/sales ratio has moved NA NA over the prior 26 months.
Below are key valuation metrics over time for HIMS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| HIMS | 2021-09-03 | 6.4 | 5.7 | -20.9 | -19.6 |
| HIMS | 2021-09-02 | 6.5 | 5.8 | -21.2 | -19.9 |
| HIMS | 2021-09-01 | 6.3 | 5.6 | -20.6 | -19.4 |
| HIMS | 2021-08-31 | 6.1 | 5.5 | -20.0 | -18.7 |
| HIMS | 2021-08-30 | 6.2 | 5.5 | -20.3 | -19.1 |
| HIMS | 2021-08-27 | 6.0 | 5.4 | -19.7 | -18.4 |
HIMS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- HIMS has a Quality Grade of C, ranking ahead of 40.35% of graded US stocks.
- HIMS's asset turnover comes in at 1.028 -- ranking 21st of 81 Healthcare stocks.
- 500 - Internal server error
The table below shows HIMS's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 1.028 | 0.752 | -0.439 |
| 2021-03-31 | 0.917 | 0.744 | -0.393 |
| 2020-12-31 | 0.807 | 0.736 | -0.105 |
| 2020-09-30 | 0.521 | 0.723 | -0.059 |
| 2020-09-30 | 0.521 | 0.723 | -0.059 |
| 2020-09-30 | 0.521 | 0.723 | -0.059 |
HIMS Stock Price Chart Interactive Chart >
HIMS Price/Volume Stats
| Current price | $4.96 | 52-week high | $10.90 |
| Prev. close | $4.79 | 52-week low | $2.72 |
| Day low | $4.63 | Volume | 684,773 |
| Day high | $4.96 | Avg. volume | 2,353,292 |
| 50-day MA | $4.08 | Dividend yield | N/A |
| 200-day MA | $5.62 | Market Cap | 1.02B |
Hims & Hers Health, Inc. (HIMS) Company Bio
Hims & Hers Health, Inc. provides health care software solutions. The Company offers multi-specialty telehealth platform that connects consumers to licensed healthcare providers, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, and primary care. Hims & Hers Health serves customers in the United States.
Latest HIMS News From Around the Web
Below are the latest news stories about Hims & Hers Health Inc that investors may wish to consider to help them evaluate HIMS as an investment opportunity.
Hims & Hers Health, Inc. (HIMS) CEO Andrew Dudum On Q4 2021 Results - Earnings Call TranscriptHims & Hers Health, Inc. (HIMS) Q4 2021 Earnings Conference Call February 22, 2022, 05:00 PM ET Company Participants Jay Spitzer - Senior VP & Investor Relations Andrew Dudum - Chief Executive Officer Yemi Okupe - Chief Financial Officer Conference Call Participants Michael Cherny - Bank of America Matthew Shea... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayGood morning, trader! |
HIMS Stock: 12 Reasons Why Hims & Hers Shares Are Soaring TodayHims & Hers Health (HIMS) stock is soaring higher on Wednesday thanks to the company's earnings report for the fourth quarter of 2021. |
Russian Stocks: What’s Going on With SBRCY, YNDX, OGZPY, NOVKY and LUKOY Today?Russian stocks are on the move today with several shares taking a massive beating on Wednesday and we're diving into that news. |
SKIN Stock: What’s Going on With The Beauty Health Company Today?The Beauty Health Company (SKIN) stock is rising higher on Wednesday following the release of its Q4 2021 earnings report. |
HIMS Price Returns
| 1-mo | 22.17% |
| 3-mo | -1.78% |
| 6-mo | -13.44% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -24.27% |
| 2021 | -55.14% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...